{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T05:30:27Z","timestamp":1733290227903,"version":"3.30.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,3]]},"DOI":"10.7759\/cureus.75056","type":"journal-article","created":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T00:53:35Z","timestamp":1733273615000},"source":"Crossref","is-referenced-by-count":0,"title":["Malignant Transformation of a Choroidal Nevus"],"prefix":"10.7759","author":[{"given":"Luxi","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiongyue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/opo.12092","article-title":"Prevalence of choroidal naevi using scanning laser ophthalmoscope","volume":"34","author":"Gordon-Shaag A","year":"2014","unstructured":"Gordon-Shaag A, Barnard S, Millodot M, et al.. Prevalence of choroidal naevi using scanning laser ophthalmoscope. Ophthalmic Physiol Opt. 2014, 34:94-101. 10.1111\/opo.12092","journal-title":"Ophthalmic Physiol Opt"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2018-312967","article-title":"Combination of multimodal imaging features predictive of choroidal nevus transformation into melanoma","volume":"103","author":"Dalvin LA","year":"2019","unstructured":"Dalvin LA, Shields CL, Ancona-Lezama DA, et al.. Combination of multimodal imaging features predictive of choroidal nevus transformation into melanoma. Br J Ophthalmol. 2019, 103:1441-7. 10.1136\/bjophthalmol-2018-312967","journal-title":"Br J Ophthalmol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2015.06.008","article-title":"Choroidal nevus in the United States adult population: racial disparities and associated factors in the National Health and Nutrition Examination Survey","volume":"122","author":"Qiu M","year":"2015","unstructured":"Qiu M, Shields CL. Choroidal nevus in the United States adult population: racial disparities and associated factors in the National Health and Nutrition Examination Survey. Ophthalmology. 2015, 122:2071-83. 10.1016\/j.ophtha.2015.06.008","journal-title":"Ophthalmology"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/medicines10010011","article-title":"Choroidal melanoma: a mini review","volume":"10","author":"Soliman N","year":"2023","unstructured":"Soliman N, Mamdouh D, Elkordi A. Choroidal melanoma: a mini review. Medicines (Basel). 2023, 10:11. 10.3390\/medicines10010011","journal-title":"Medicines (Basel)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2005.06.011","article-title":"Estimating the risk of malignant transformation of a choroidal nevus","volume":"112","author":"Singh AD","year":"2005","unstructured":"Singh AD, Kalyani P, Topham A. Estimating the risk of malignant transformation of a choroidal nevus. Ophthalmology. 2005, 112:1784-9. 10.1016\/j.ophtha.2005.06.011","journal-title":"Ophthalmology"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000002440","article-title":"Choroidal nevus imaging features in 3,806 cases and risk factors for transformation into melanoma in 2,355 cases: the 2020 Taylor R. Smith and Victor T. Curtin lecture","volume":"39","author":"Shields CL","year":"2019","unstructured":"Shields CL, Dalvin LA, Ancona-Lezama D, et al.. Choroidal nevus imaging features in 3,806 cases and risk factors for transformation into melanoma in 2,355 cases: the 2020 Taylor R. Smith and Victor T. Curtin lecture. Retina. 2019, 39:1840-51. 10.1097\/IAE.0000000000002440","journal-title":"Retina"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1001\/archophthalmol.2009.151","article-title":"Choroidal nevus transformation into melanoma: analysis of 2514 consecutive cases","volume":"127","author":"Shields CL","year":"2009","unstructured":"Shields CL, Furuta M, Berman EL, et al.. Choroidal nevus transformation into melanoma: analysis of 2514 consecutive cases. Arch Ophthalmol. 2009, 127:981-7. 10.1001\/archophthalmol.2009.151","journal-title":"Arch Ophthalmol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2016-309034","article-title":"Metastatic disease from uveal melanoma: treatment options and future prospects","volume":"101","author":"Carvajal RD","year":"2017","unstructured":"Carvajal RD, Schwartz GK, Tezel T, Marr B, Francis JH, Nathan PD. Metastatic disease from uveal melanoma: treatment options and future prospects. Br J Ophthalmol. 2017, 101:38-44. 10.1136\/bjophthalmol-2016-309034","journal-title":"Br J Ophthalmol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.123.12.1639","article-title":"Development of metastatic disease after enrollment in the COMS trials for treatment of choroidal melanoma: Collaborative Ocular Melanoma Study Group Report No. 26","volume":"123","author":"Diener-West M","year":"2005","unstructured":"Diener-West M, Reynolds SM, Agugliaro DJ, et al.. Development of metastatic disease after enrollment in the COMS trials for treatment of choroidal melanoma: Collaborative Ocular Melanoma Study Group Report No. 26. Arch Ophthalmol. 2005, 123:1639-43. 10.1001\/archopht.123.12.1639","journal-title":"Arch Ophthalmol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2011.05.003","article-title":"Estimating prognosis for survival after treatment of choroidal melanoma","volume":"30","author":"Damato B","year":"2011","unstructured":"Damato B, Eleuteri A, Taktak AF, Coupland SE. Estimating prognosis for survival after treatment of choroidal melanoma. Prog Retin Eye Res. 2011, 30:285-95. 10.1016\/j.preteyeres.2011.05.003","journal-title":"Prog Retin Eye Res"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.03-0538","article-title":"Very long-term prognosis of patients with malignant uveal melanoma","volume":"44","author":"Kujala E","year":"2003","unstructured":"Kujala E, M\u00e4kitie T, Kivel\u00e4 T. Very long-term prognosis of patients with malignant uveal melanoma. Invest Ophthalmol Vis Sci. 2003, 44:4651-9. 10.1167\/iovs.03-0538","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.02-1215","article-title":"Nucleolar diameter and microvascular factors as independent predictors of mortality from malignant melanoma of the choroid and ciliary body","volume":"44","author":"Al-Jamal RT","year":"2003","unstructured":"Al-Jamal RT, M\u00e4kitie T, Kivel\u00e4 T. Nucleolar diameter and microvascular factors as independent predictors of mortality from malignant melanoma of the choroid and ciliary body. Invest Ophthalmol Vis Sci. 2003, 44:2381-9. 10.1167\/iovs.02-1215","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1987.01060060087039","article-title":"Death from uveal melanoma. Number of epithelioid cells and inverse SD of nucleolar area as prognostic factors","volume":"105","author":"Seddon JM","year":"1987","unstructured":"Seddon JM, Polivogianis L, Hsieh CC, Albert DM, Gamel JW, Gragoudas ES. Death from uveal melanoma. Number of epithelioid cells and inverse SD of nucleolar area as prognostic factors. Arch Ophthalmol. 1987, 105:801-6. 10.1001\/archopht.1987.01060060087039","journal-title":"Arch Ophthalmol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.4103\/ijo.IJO_1724_19","article-title":"Acquired retinal astrocytoma: transpupillary thermotherapy may be a viable alternative treatment option","volume":"68","author":"Dubey D","year":"2020","unstructured":"Dubey D, Ramanjulu R, Shanmugam MP, Mishra DK. Acquired retinal astrocytoma: transpupillary thermotherapy may be a viable alternative treatment option. Indian J Ophthalmol. 2020, 68:1446-7. 10.4103\/ijo.IJO_1724_19","journal-title":"Indian J Ophthalmol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2014.09.029","article-title":"Primary transpupillary thermotherapy for choroidal melanoma in 391 cases: importance of risk factors in tumor control","volume":"122","author":"Mashayekhi A","year":"2015","unstructured":"Mashayekhi A, Shields CL, Rishi P, et al.. Primary transpupillary thermotherapy for choroidal melanoma in 391 cases: importance of risk factors in tumor control. Ophthalmology. 2015, 122:600-9. 10.1016\/j.ophtha.2014.09.029","journal-title":"Ophthalmology"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2014.08.046","article-title":"Management of posterior uveal melanoma: past, present, and future: the 2014 Charles L. Schepens lecture","volume":"122","author":"Shields JA","year":"2015","unstructured":"Shields JA, Shields CL. Management of posterior uveal melanoma: past, present, and future: the 2014 Charles L. Schepens lecture. Ophthalmology. 2015, 122:414-28. 10.1016\/j.ophtha.2014.08.046","journal-title":"Ophthalmology"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.det.2022.07.007","article-title":"Targeted therapy and immunotherapy in melanoma","volume":"41","author":"Lazaroff J","year":"2023","unstructured":"Lazaroff J, Bolotin D. Targeted therapy and immunotherapy in melanoma. Dermatol Clin. 2023, 41:65-77. 10.1016\/j.det.2022.07.007","journal-title":"Dermatol Clin"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-023-02060-8","article-title":"IL-10-expressing CAR T cells resist dysfunction and mediate durable clearance of solid tumors and metastases","volume":"42","author":"Zhao Y","year":"2024","unstructured":"Zhao Y, Chen J, Andreatta M, et al.. IL-10-expressing CAR T cells resist dysfunction and mediate durable clearance of solid tumors and metastases. Nat Biotechnol. 2024, 42:1693-704. 10.1038\/s41587-023-02060-8","journal-title":"Nat Biotechnol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14133094","article-title":"Recent advances and challenges in uveal melanoma immunotherapy","volume":"14","author":"Fu Y","year":"2022","unstructured":"Fu Y, Xiao W, Mao Y. Recent advances and challenges in uveal melanoma immunotherapy. Cancers (Basel). 2022, 14:3094. 10.3390\/cancers14133094","journal-title":"Cancers (Basel)"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1159\/000524485","article-title":"Dynamic observation: immune-privileged microenvironment limited the effectiveness of immunotherapy in an intraocular metastasis mouse model","volume":"65","author":"Tao T","year":"2022","unstructured":"Tao T, Liu Y, Zhang J, Huang L, Tao Y. Dynamic observation: immune-privileged microenvironment limited the effectiveness of immunotherapy in an intraocular metastasis mouse model. Ophthalmic Res. 2022, 65:584-94. 10.1159\/000524485","journal-title":"Ophthalmic Res"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/316986-malignant-transformation-of-a-choroidal-nevus","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T00:53:36Z","timestamp":1733273616000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/316986-malignant-transformation-of-a-choroidal-nevus"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,3]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.75056","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12,3]]}}}